Tobias Bauch

Title: Innovations in Renal Injury Models by Tobias Bauch

Introduction

Tobias Bauch is an accomplished inventor based in Wuppertal, Germany. He has made significant contributions to the field of medical research, particularly in the development of models for renal injury. His work focuses on creating effective methods to screen molecules for the treatment of renal injuries.

Latest Patents

Tobias Bauch holds a patent for a "Method for creating a renal injury model to screen molecules for the treatment of renal injury." This invention relates to short-term renal injury models and methods for creating these models. The models and methods can be utilized for identifying, testing, or characterizing candidate molecules regarding their suitability to treat renal injury. The methods involve inducing renal injury in a test subject by administering a bolus of a renal injury inducer subcutaneously, in a dosage sufficient to induce renal injury. Various readouts for renal injury are provided, such as the albumin creatinine ratio (ACR) determined from a urine sample taken from the subject, or the development of transcutaneous fluorescence after the injection of a fluorescent molecule. Based on these readouts, the degree of renal injury and/or alteration of GFR can be determined.

Career Highlights

Tobias Bauch is currently employed at Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His innovative work in renal injury models has positioned him as a key figure in the research community.

Collaborations

He collaborates with talented coworkers, including Simone Romoli and Karoline Dröbner, who contribute to the advancement of research in this critical area.

Conclusion

Tobias Bauch's contributions to the field of renal injury research through his innovative patent demonstrate his commitment to improving medical treatments. His work continues to pave the way for advancements in the understanding and treatment of renal injuries.